Suppr超能文献

中国抗击新冠疫情的策略与进展

Strategies and Advances in Combating COVID-19 in China.

作者信息

Liu Wei, Guan Wei-Jie, Zhong Nan-Shan

机构信息

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510120, China.

出版信息

Engineering (Beijing). 2020 Oct;6(10):1076-1084. doi: 10.1016/j.eng.2020.10.003. Epub 2020 Oct 15.

Abstract

Coronavirus disease 2019 (COVID-19)-the third in a series of coronavirus infections-has caused a global public health event in the 21st century, resulting in substantial global morbidity and mortality. Building on its legacy of managing severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), China has played a key role in the scientific community by revealing the viral transmission routes and clinical characteristics of COVID-19 and developing novel therapeutic interventions and vaccines. Despite these rapid scientific and technological advances, uncertainties remain in tracing the original sources of infection, determining the routes of transmission and pathogenesis, and addressing the lack of targeted clinical management of COVID-19. Here, we summarize the major COVID-19 research advances in China in order to provide useful information for global pandemic control.

摘要

2019冠状病毒病(COVID-19)——一系列冠状病毒感染中的第三种——已在21世纪引发了一场全球公共卫生事件,导致全球大量发病和死亡。基于其在管理严重急性呼吸综合征(SARS)和中东呼吸综合征(MERS)方面的经验,中国通过揭示COVID-19的病毒传播途径和临床特征以及开发新的治疗干预措施和疫苗,在科学界发挥了关键作用。尽管取得了这些迅速的科技进步,但在追踪感染源、确定传播途径和发病机制以及解决COVID-19缺乏针对性临床管理方面仍存在不确定性。在此,我们总结了中国在COVID-19方面的主要研究进展,以便为全球疫情防控提供有用信息。

相似文献

1
Strategies and Advances in Combating COVID-19 in China.中国抗击新冠疫情的策略与进展
Engineering (Beijing). 2020 Oct;6(10):1076-1084. doi: 10.1016/j.eng.2020.10.003. Epub 2020 Oct 15.
3
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.

引用本文的文献

10
Public Health Measures and the Control of COVID-19 in China.公共卫生措施与中国 COVID-19 控制
Clin Rev Allergy Immunol. 2023 Feb;64(1):1-16. doi: 10.1007/s12016-021-08900-2. Epub 2021 Sep 18.

本文引用的文献

5
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.轻度新冠病毒感染中抗新冠病毒-2抗体的丧失
N Engl J Med. 2020 Oct 22;383(17):1695-1696. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验